1. Home
  2. TNON vs SILO Comparison

TNON vs SILO Comparison

Compare TNON & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

BUY

Current Price

$2.98

Market Cap

2.8M

Sector

Health Care

ML Signal

BUY

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$1.49

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNON
SILO
Founded
2012
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
TNON
SILO
Price
$2.98
$1.49
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $44.38
N/A
AVG Volume (30 Days)
★ 915.4K
43.2K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
57.98
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
$72,102.00
Revenue This Year
$46.86
N/A
Revenue Next Year
$63.99
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$2.40
$1.30
52 Week High
$50.40
$19.92

Technical Indicators

Market Signals
Indicator
TNON
SILO
Relative Strength Index (RSI) 40.23 22.45
Support Level $2.54 $1.30
Resistance Level $4.18 $4.80
Average True Range (ATR) 0.24 0.11
MACD 0.09 0.05
Stochastic Oscillator 22.19 27.74

Price Performance

Historical Comparison
TNON
SILO

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: